Open Access

APRIL, BCMA and TACI proteins are abnormally expressed in non-small cell lung cancer

  • Authors:
    • Hengli Dou
    • Zhaohua Yan
    • Meng Zhang
    • Xiaoxin Xu
  • View Affiliations

  • Published online on: September 6, 2016     https://doi.org/10.3892/ol.2016.5095
  • Pages: 3351-3355
  • Copyright: © Dou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Lung cancer is the leading cause of cancer‑associated mortality. Non‑small cell lung cancer (NSCLC) accounts for >80% of lung cancers. The overall survival for NSCLC is dismal, with a 5‑year survival of <5% for patients. Thus, identifying an effective biomarker for early diagnosis of lung cancer is the first essential step to reduce mortality. It has been recognized that certain inflammatory and immune responses are important in lung cancer development and prevention. The present study demonstrated that, in NSCLC, a proliferation‑inducing ligand (APRIL), B‑cell maturation antigen (BCMA)and transmembrane activator and CAML interactor (TACI) proteins are abnormally expressed by immunohistochemistry, reverse transcription‑quantitative polymerase chain reaction and western blotting. In addition, the expression of APRIL, BCMA and TACI were observed to be involved in extracellular signal‑regulated kinase (ERK)1/2 activation in A549 cells. Overall, the present study provides evidence that APRIL and its receptors, BCMA and TACI, may play roles in the biological processes of NSCLC tumors through the ERK1/2 signaling pathway.
View Figures
View References

Related Articles

Journal Cover

November-2016
Volume 12 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Dou H, Yan Z, Zhang M and Xu X: APRIL, BCMA and TACI proteins are abnormally expressed in non-small cell lung cancer. Oncol Lett 12: 3351-3355, 2016
APA
Dou, H., Yan, Z., Zhang, M., & Xu, X. (2016). APRIL, BCMA and TACI proteins are abnormally expressed in non-small cell lung cancer. Oncology Letters, 12, 3351-3355. https://doi.org/10.3892/ol.2016.5095
MLA
Dou, H., Yan, Z., Zhang, M., Xu, X."APRIL, BCMA and TACI proteins are abnormally expressed in non-small cell lung cancer". Oncology Letters 12.5 (2016): 3351-3355.
Chicago
Dou, H., Yan, Z., Zhang, M., Xu, X."APRIL, BCMA and TACI proteins are abnormally expressed in non-small cell lung cancer". Oncology Letters 12, no. 5 (2016): 3351-3355. https://doi.org/10.3892/ol.2016.5095